VAM
IMGN

Visium Asset Management’s Immunogen Inc IMGN Stock Holding History

Visium Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-13,215
Closed -$190K – 1233
2015
Q2 		$190K Sell
13,215
-11,985
-48% -$132K ﹤0.01% 993
2015
Q1 		$226K Buy
+25,200
New +$183K ﹤0.01% 895

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Visium Asset Management's IMGN Position: Q3 2015 in Review

Visium Asset Management sold out of Immunogen Inc (IMGN) in Q3 2015, closing a stake of 13,215 shares — an estimated $190K sold.

Visium Asset Management first reported a position in IMGN in Q1 2015 and held it in 2 quarters. The position peaked at $226K in Q1 2015. 151 funds tracked by Wall St. Rank hold IMGN as of Q3 2015.

  • Visium Asset Management reported no remaining Immunogen Inc position as of Q3 2015 after selling out during the quarter.
  • Visium Asset Management sold 13,215 Immunogen Inc shares in Q3 2015, an estimated $190K.
  • Visium Asset Management first reported a position in Immunogen Inc in Q1 2015 and held it in 2 quarters.
  • Visium Asset Management's Immunogen Inc position peaked at $226K in Q1 2015.
  • 151 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2015.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.